These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32157485)

  • 1. Axonal protection by a small molecule SIRT1 activator, SRT2104, with alteration of autophagy in TNF-induced optic nerve degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Tokuda N; Kogo J; Takagi H
    Jpn J Ophthalmol; 2020 May; 64(3):298-303. PubMed ID: 32157485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal Protection by Ripasudil, a Rho Kinase Inhibitor, via Modulating Autophagy in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Kojima K; Shiono A; Kogo J; Tokuda N; Takagi H
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5056-5064. PubMed ID: 28980003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration.
    Kitaoka Y; Kojima K; Munemasa Y; Sase K; Takagi H
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1291-6. PubMed ID: 25863674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Takagi H
    Mol Neurobiol; 2020 Dec; 57(12):4952-4960. PubMed ID: 32820458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal protection by modulation of p62 expression in TNF-induced optic nerve degeneration.
    Kojima K; Kitaoka Y; Munemasa Y; Hirano A; Sase K; Takagi H
    Neurosci Lett; 2014 Oct; 581():37-41. PubMed ID: 25150927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Kogo J; Tokuda N; Takagi H
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):4. PubMed ID: 34982146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal protection by 17β-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy.
    Kitaoka Y; Munemasa Y; Hayashi Y; Kuribayashi J; Koseki N; Kojima K; Kumai T; Ueno S
    Endocrinology; 2011 Jul; 152(7):2775-85. PubMed ID: 21586560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal protection by thioredoxin-1 with inhibition of interleukin-1β in TNF-induced optic nerve degeneration.
    Kitaoka Y; Tanito M; Kojima K; Sase K; Kaidzu S; Munemasa Y; Takagi H; Ohira A; Yodoi J
    Exp Eye Res; 2016 Nov; 152():71-76. PubMed ID: 27664905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal Protection by Tacrolimus with Inhibition of NFATc1 in TNF-Induced Optic Nerve Degeneration.
    Tsukahara C; Sase K; Fujita N; Takagi H; Kitaoka Y
    Neurochem Res; 2019 Jul; 44(7):1726-1735. PubMed ID: 31087207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38 ameliorates axonal loss with modulation of autophagy in TNF-induced optic nerve damage.
    Sase K; Tsukahara C; Fujita N; Arizono I; Otsubo M; Kitaoka Y
    Int Ophthalmol; 2023 Sep; 43(9):3067-3074. PubMed ID: 37062014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akebia Saponin D prevents axonal loss against TNF-induced optic nerve damage with autophagy modulation.
    Sase K; Tsukahara C; Fujita N; Arizono I; Takagi H; Kitaoka Y
    Mol Biol Rep; 2020 Dec; 47(12):9733-9738. PubMed ID: 33249542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration.
    Fujino H; Kitaoka Y; Hayashi Y; Munemasa Y; Takeda H; Kumai T; Kobayashi S; Ueno S
    Acta Neuropathol; 2009 Jan; 117(1):75-84. PubMed ID: 18830614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration.
    Kitaoka Y; Munemasa Y; Kojima K; Hirano A; Ueno S; Takagi H
    Cell Death Dis; 2013 Oct; 4(10):e860. PubMed ID: 24136224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal protection via modulation of the amyloidogenic pathway in tumor necrosis factor-induced optic neuropathy.
    Kojima K; Kitaoka Y; Munemasa Y; Ueno S
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7675-83. PubMed ID: 23111606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65.
    Kitaoka Y; Kitaoka Y; Kwong JM; Ross-Cisneros FN; Wang J; Tsai RK; Sadun AA; Lam TT
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1448-57. PubMed ID: 16565378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal protection by short-term hyperglycemia with involvement of autophagy in TNF-induced optic nerve degeneration.
    Sase K; Kitaoka Y; Munemasa Y; Kojima K; Takagi H
    Front Cell Neurosci; 2015; 9():425. PubMed ID: 26578885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy.
    Kitaoka Y; Hayashi Y; Kumai T; Takeda H; Munemasa Y; Fujino H; Kitaoka Y; Ueno S; Sadun AA; Lam TT
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):915-27. PubMed ID: 19606062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes.
    Baksi A; Kraydashenko O; Zalevkaya A; Stets R; Elliott P; Haddad J; Hoffmann E; Vlasuk GP; Jacobson EW
    Br J Clin Pharmacol; 2014 Jul; 78(1):69-77. PubMed ID: 24446723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.
    Sands BE; Joshi S; Haddad J; Freudenberg JM; Oommen DE; Hoffmann E; McCallum SW; Jacobson E
    Inflamm Bowel Dis; 2016 Mar; 22(3):607-14. PubMed ID: 26595549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
    Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.